Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Lacosamide-13C, D3 Solution, 1.0 mg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco L0321ML
Description
An internal standard suitable for GC/MS or LC/MS applications in lacosamide testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat™.Specifications
75-05-8 | |
UN 1648 3 / PGII | |
254.30 | |
1 mL |
13CC12D3H15N2O3 | |
1.0 mg/mL in acetonitrile | |
Ampule | |
2°C (35.6°F) - closed cup |
Safety and Handling
H332-H319
H312
Recommended Storage : -20°C
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation